Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia?

Nature Clinical Practice Oncology volume 1, pages 16–17 (2004)Cite this article

boxed-textLipshultz SE et al . (2004) The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351: 145–153

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wexler LH et al. (1996) Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol 14: 362–372

    Article  CAS  Google Scholar 

  2. Silber JH and Kaizer H (1988) Marginal analysis and the dose-response curve. Med Pediatr Oncol 16: 344–348

    Article  CAS  Google Scholar 

  3. Silber JH (1994) The anthracycline cardiotoxicity debate. Pediatrics 93: 779–781

    Google Scholar 

  4. Silber JH et al. (2004) Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 5: 820–828

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by David Bruce, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Pediatrics, Anesthesia, and Health Care Systems at The University of Pennsylvania, and Director of the Center for Outcomes Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

    Jeffrey H Silber

Authors
  1. Jeffrey H Silber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey H Silber.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silber, J. Can dexrazoxane reduce myocardial injury in anthracycline-treated children with acute lymphoblastic leukemia?. Nat Rev Clin Oncol 1, 16–17 (2004). https://doi.org/10.1038/ncponc0023

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0023

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing